chr16-2090293-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001009944.3(PKD1):c.12436G>A(p.Val4146Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00378 in 1,609,992 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0033 ( 3 hom., cov: 34)
Exomes 𝑓: 0.0038 ( 28 hom. )
Consequence
PKD1
NM_001009944.3 missense
NM_001009944.3 missense
Scores
7
12
Clinical Significance
Conservation
PhyloP100: 2.77
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.010210127).
BP6
Variant 16-2090293-C-T is Benign according to our data. Variant chr16-2090293-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 256919.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2090293-C-T is described in Lovd as [Benign]. Variant chr16-2090293-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00384 (5592/1457686) while in subpopulation MID AF= 0.0175 (101/5760). AF 95% confidence interval is 0.0148. There are 28 homozygotes in gnomad4_exome. There are 2963 alleles in male gnomad4_exome subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High AC in GnomAd4 at 501 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.12436G>A | p.Val4146Ile | missense_variant | 45/46 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.12436G>A | p.Val4146Ile | missense_variant | 45/46 | 1 | NM_001009944.3 | ENSP00000262304.4 | ||
PKD1 | ENST00000423118.5 | c.12433G>A | p.Val4145Ile | missense_variant | 45/46 | 1 | ENSP00000399501.1 | |||
PKD1 | ENST00000472577.1 | n.464G>A | non_coding_transcript_exon_variant | 2/3 | 2 | |||||
MIR1225 | ENST00000408729.1 | n.-9G>A | upstream_gene_variant | 6 |
Frequencies
GnomAD3 genomes AF: 0.00329 AC: 501AN: 152188Hom.: 3 Cov.: 34
GnomAD3 genomes
AF:
AC:
501
AN:
152188
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00439 AC: 1076AN: 244946Hom.: 5 AF XY: 0.00484 AC XY: 645AN XY: 133308
GnomAD3 exomes
AF:
AC:
1076
AN:
244946
Hom.:
AF XY:
AC XY:
645
AN XY:
133308
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00384 AC: 5592AN: 1457686Hom.: 28 Cov.: 34 AF XY: 0.00409 AC XY: 2963AN XY: 724654
GnomAD4 exome
AF:
AC:
5592
AN:
1457686
Hom.:
Cov.:
34
AF XY:
AC XY:
2963
AN XY:
724654
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00329 AC: 501AN: 152306Hom.: 3 Cov.: 34 AF XY: 0.00290 AC XY: 216AN XY: 74472
GnomAD4 genome
AF:
AC:
501
AN:
152306
Hom.:
Cov.:
34
AF XY:
AC XY:
216
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
8
ALSPAC
AF:
AC:
11
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
37
ExAC
AF:
AC:
569
Asia WGS
AF:
AC:
17
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | PKD1: BS2 - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 16, 2021 | This variant is associated with the following publications: (PMID: 22383692, 10200984, 27843768, 27499327, 27401137, 11967008, 31488014) - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Polycystic kidney disease, adult type Benign:2
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 08, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 23, 2017 | - - |
Polycystic kidney disease Benign:1
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PKD1 p.Val4146Ile variant was identified in 8 of 1080 proband chromosomes (frequency: 0.007) from individuals or families with ADPKD (Badenas 1999, Rossetti 2012, Rossetti 2002, Stekrova 2009). The variant was also identified in the following databases: dbSNP (ID: rs148478410) as “With Likely benign allele”, ClinVar (1x, as likely benign by Prevention Genetics), LOVD 3.0 (1x, with unknown effect, 1x as "Probably does not affect function"), ADPKD Mutation Database (as likely neutral). The variant was not identified in the PKD1-LOVD database. The variant was identified in control databases in 1211 of 271698 (5 homozygous) chromosomes at a frequency of 0.004457 in the following populations: African in 11 of 23782 chromosomes (freq. 0.00046), other in 41 of 6358 chromosomes (freq. 0.0064), Latino in 102 of 34238 chromosomes (freq. 0.003), European in 644 of 12418 (2 homozygous) chromosomes (freq. 0.005), Ashkenazi Jewish in 30 of 9890 chromosomes (freq. 0.003), East Asian in 1 of 18826 chromosomes (freq. 0.00005), Finnish in 117 of 25656 chromosomes (freq. 0.0045), and South Asian in 265 of 30530 (3 homozygous) chromosomes (freq. 0.0086), increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Consortium Feb 27, 2017). A co-occurring pathogenic PKD1 variant (c.7864-1G>T) was identified in 1 individual with ADPKD in our laboratory, increasing the likelihood that p.Val4146Ile variant does not have clinical significance. The p.Val4146 residue is conserved in mammals but not in more distantly related organisms however four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 4 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing. However, this information is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at